A New Generation of Pharmaceutical Company
SinoVeda Canada Inc. is a private Canadian company that was founded by two pharmaceutical scientists in 2006.
We recognize the treatment of a disease is a complicated process; it requires multiple therapeutic agents for effective treatment. By adopting the principle of a multiple ingredient/multiple target approach, we envision a conversion of therapeutically active botanicals to highly effective pharmaceuticals. We use our patent pending drug development technology (PPT®) to effectively develop a continuum of highly standardized nutraceutical and pharmaceutical products with proven therapeutic efficacy.
Board of Directors
- Grant Ferrier, B.S., Chairman, San Diego, CA (CEO & co-founder, Nutrition, Capital Network)
- Yun Tam, Edmonton, Ph.D., Edmonton, AB (Co-founder, President & CSO, SinoVeda Canada Inc.)
- Nuzhat Tam-Zaman, Ph.D., Edmonton, AB (Co-founder, Vice President, International & Regulatory Affairs, SinoVeda Canada Inc.).
- Keith Chan, Ph.D., Taipei, Taiwan (Professor, Graduate Institute of Intellectual Property, College of Commerce, National Chengchi University and adjunct Professor and Advisor, Research Center for Drug Discovery, National Ming University)
- Paul Braconnier, CA, Edmonton, AB (President & CEO, Global IQ Inc.)
- Alex Lee, B.A., Hong Kong (Managing Director, Phoenix Capital Asia Limited)
Senior Management
- Grant Ferrier, B.S., Executive Chairman
- Yun Tam, Ph.D., President & Chief Scientific Officer
- Nuzhat Tam-Zaman, Ph.D., Vice President, International & Regulatory Affair
- Al Gourley, CA, Chief Financial Officer (Former Chairman & CEO, Cantega Technologies Inc.)
